Organization Overview
Historical Acquisition Tree
Alternative names
Key: Emergent BioSolutions (3) Acquired (1)
anthrax immune globulin (Anthrasil) (2015 NDA)
naloxone (narcan) (2015)
somatropin (protropin) (2008)
Key: Emergent BioSolutions (0) Acquired (5)
Key: Emergent BioSolutions (3) Acquired (4)
Key: Emergent BioSolutions (12) Acquired (5)
anthrax immune globulin (Anthrasil) (1 trial)
Anti-Influenza Immunoglobulin (1 trial)
cyclophosphamide (cytoxan) (1 trial)
doxycycline (vibramycin) (1 trial)
Key: Emergent BioSolutions (10) Acquired (13)
botulinum antitoxin heptavalent (a b c d e f g) - (equine) (1 trial)
botulism antitoxin bivalent (equine) types a and b (1 trial)
Key: Emergent BioSolutions (0) Acquired (2)
Anthrax (Phase 3)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Constriction, Pathologic (Phase 1)
Glomerulonephritis, Membranous (Phase 1)
Infections (Phase 1)
Influenza, Human (Phase 2)
Kidney Diseases (Phase 1)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Mycoses (Phase 3)
Mycosis Fungoides (Phase 3)
Sezary Syndrome (Phase 3)
Spinal Stenosis (Phase 1)
Spondylolisthesis (Phase 1)
Syndrome (Phase 3)
Tuberculosis (Phase 1)
Typhoid Fever (Phase 2)
Virus Diseases (Phase 1)
Zika Virus Infection (Phase 1)